These experts will discuss critical elements of commercialization including fundraising, user needs evaluation, human-centered design and iterative prototyping.

TORONTO (PRWEB)
June 28, 2023

An exciting, free webinar in the medical device industry is set to happen, with insights into innovation strategies for growth-stage companies to be shared by some of the industry’s most experienced professionals. This webinar will provide an opportunity for attendees to hear from founders, CEOs and executives about the importance of innovation for growth-stage companies and gain valuable insights into strategies for bringing differentiated medical devices to market.

The webinar, titled “Medical Technology: The Innovation Imperative for Growth Stage Companies,” is being moderated by Brandon Bogdalek, Vice President of Demand Generation at Veranex, a healthcare product innovation and commercialization partner known for its human-centered design and deep engineering capability. Bogdalek, with his wealth of experience in outsourced innovation and commercialization projects, will guide the conversation with three industry-leading panelists.

The panel comprises Michael Hill, Global Head of Science & Technology and Innovation at Science Innovations L.L.C. and Adjunct Associate Professor at the Case Western Reserve University School of Engineering and Weatherhead School of Management; Nancy Schoenbrunner, Chief Executive Officer of AmplifiDx; and Tom Burke, Partner and Founder of Vail Scientific. These experts will discuss critical elements of commercialization including fundraising, user needs evaluation, human-centered design and iterative prototyping.

Veranex partnered with Xtalks for this webinar. Veranex is renowned for its fully integrated concept-to-commercialization solution in medical technology product development, boasting ISO 13485-certification, FDA-registration and over 30 years of experience. This partnership with Xtalks, a leader in providing educational webinars across various industries, aligns with their shared mission of promoting new thinking and developing the future of MedTech.

Don’t miss this chance to gain insights from industry leaders on innovation in the medical device sector. The webinar is scheduled for Friday, July 14, 2023, at 1pm EDT (10am PDT).

For more information, or to register for this event, visit Medical Technology: The Innovation Imperative for Growth Stage Companies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

SANTA FE, N.M. (PRWEB)
June 28, 2023

Meperia, a cost management and revenue enhancement solutions provider focused on the healthcare supply chain, announced today it has successfully completed its System and Organizational Controls SOC 2® Type 2 examination on controls relevant to Security, Availability, and Confidentiality for its Strategic Sourcing platform.

Developed by the American Institute of Certified Public Accountants (AICPA), the SOC 2® Type 2 examination provides reasonable assurance to users about the suitability of the design of the company’s controls placed into operation along with their operating effectiveness against the relevant Trust Services Criteria for a period of time.

“Our technology provides a competitive advantage, but it is the peace of mind we offer customers backed by the SOC 2 report that truly demonstrates our unwavering dedication to compliance solutions,” said Tom Frith, Executive Vice President. “We take pride in granting them the reassurance they deserve.”

Meperia chose 360 Advanced, Inc., a licensed CPA firm, to perform the demanding third-party SOC examination.

“The SOC 2 Type 2 takes us through a detailed review of the past year, reviewing our policies and procedures to verify that our work conforms to the standards we set,” said Michael Hannemann, VP of Technology. “We appreciate the guidance from 360 Advanced to navigate through this process.”

About Meperia

Meperia is the first supply chain content enabler to bring predictive intelligence solutions to the healthcare market. Our patented artificial intelligence imitates the ease of consumer on-line shopping. Meperia’s SaaS-based solution puts controls and real-time visibility around an organization’s spend at the point of requisitioning to ensure every purchase is on contract, on price and on target to their product formulary goals—before users buy! As visionaries, our industry firsts include data normalization, content management solutions, and our new implant management solution. Learn more at meperia.com.

For Meperia inquiries, please contact:

Leslie Haan, Director of Marketing

563-581-4604

lhaan@meperia.com

About 360 Advanced

360 Advanced is Making Better Businesses through their client-centric cybersecurity and compliance offerings. For nearly 20 years, 360 Advanced has delivered integrated compliance solutions to a global base of clients in a wide range of industries, from tech startups to the Fortune 500. Their cybersecurity and compliance offerings include ISO 27001, HITRUST, SOC, Penetration Testing, Risk Assessments, and more. To learn more about their services, visit 360 Advanced.

For more information on compliance solutions, please contact Patrick Tolliver:

ptolliver@360advanced.com.

Media Contact: Julie Butterfield

jbutterfield@360advanced.com

Share article on social media or email:

We must continue to develop programs and services that enable clients to meet the ever-changing and often complicated regulatory requirements for their container and package systems.

CLIFTON, N.J. (PRWEB)
June 28, 2023

CS Analytical Laboratory, the world’s only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems, is excited to announce a variety of notable achievements that have taken place over the first half of 2023.

“To remain relevant and deliver value to the marketplace, we must continue to develop programs and services that enable clients to meet the ever-changing and often complicated regulatory requirements for their container and package systems. The CS Analytical Team is committed to this endeavor by making it our mission to share our experience, knowledge and commitment to regulatory compliance with each client and bring an “exceeds expectations” level of service to each test program,” noted CEO Brian Mulhall.

The CS Analytical Team offers comprehensive CCI method development, validation, and analysis, as well as USP/EP/JP physical performance tests and physicochemical tests for all common or unique primary packaging components and systems. In addition, CS Analytical offers a host of support and complimentary testing programs that ensure all aspects of the regulatory requirements are met for any type of container system. Whether a unique product storage device or a challenging and oversize IV bag system, the CS Analytical Team has the knowledge and hands-on experience to develop a qualification test program that ensures all regulatory compliance factors are met.

About CS Analytical Laboratory

The only FDA regulated, cGMP laboratory dedicated exclusively to the complex world of drug and medical device container and package qualification testing, the CS Analytical Team includes the world’s leading experts on all relevant USP and EP requirements and the thought leaders and pioneers on CCI (container closure integrity – CCI) testing. Offering a full suite of laboratory services to include all USP, EP and JP procedures specific to glass, plastic and elastomers as well as complete USP 1207 services that span basic feasibility studies, component qualification programs and advanced method development and validation for helium leak testing, vacuum decay, high voltage and headspace analysis leak testing. CS Analytical is the one source that can ensure your medical product container and package system meets the strict and complex regulatory requirements.

Share article on social media or email:

The Ocean Tomo Cannabis Industry Report pairs unique insights related to the science, technology, regulatory, banking, and intellectual property considerations impacting cannabis business value.

CHICAGO (PRWEB)
June 27, 2023

Ocean Tomo, a part of J.S. Held, releases its Cannabis Industry Report exploring the intellectual property (IP) protection limitations, legal & banking challenges and regulatory complexity facing the Cannabis Industry. The report is available for download here: https://oceantomo.com/download-cannabis-report/.

Cannabis continues to struggle in the public markets. “Top players in the cannabis market underperformed the S&P and the Dow in 2022 and 2023, with significantly higher volatility; market uncertainty spurred by inconsistent legal status, regulations, and banking challenges are creating a challenging environment for public company performance”, noted Transaction Advisory Managing Director, Ryan Zurek.

Cannabis mergers and acquisitions (M&As) reflect challenges faced by the industry. Larger deals face mounting challenges such as rising acquisition costs, regulatory hurdles, and an overinflated market where sellers remain emotionally attached to outdated valuations. In contrast, smaller deals present opportunities for cannabis entrepreneurs to enter new markets, either geographically or through ancillary businesses. Ocean Tomo Cannabis Industry Analyst Cameron Pirochta cites industry insiders who expect to witness a surge in smaller deals within the cannabis market in 2023. He adds, “Fierce competition and a progressively challenging business climate compel cannabis entrepreneurs to consider selling their distressed businesses.”

J.S. Held compliance and receivership management technical expert Paula Durham notes, “Due to the federal illegality of cannabis, U.S. bankruptcy courts do not protect cannabis-related businesses (CRBs), making state court receiverships a viable alternative for distressed CRBs. Receiverships can address business insolvency, serve as a temporary solution during legal disputes, and provide stability while litigation proceeds or a restructuring plan is developed.”

Securing intellectual property in the cannabis industry is challenging due to federal illegality.

Despite this challenge, intellectual property has emerged as an important factor in cannabis M&As. A notable example is British American Tobacco’s recent acquisition of a nearly 20% stake in the Canadian cannabis producer Organigram for $175 million. The acquisition aims to develop core intellectual property for cannabinoid-based products and delivery systems, emphasizing the significance of product innovation and fundamental research and development (R&D) in gaining a competitive edge within the cannabis industry.

Despite federal roadblocks, cultural acceptance, expanded pharmacological use, progressive state-level deregulation, and support from Acannability, the industry’s first member-driven, direct-to-consumer, and supply chain advertising cooperative, the cannabis industry continues to expand at an impressive rate.

Daniel Principe, who oversees the Industry Reports, shares, “the Cannabis Industry report demonstrates how Ocean Tomo’s intellectual property analyses and insights can be further strengthened when paired with technical experts in the relevant industry. As our IP professionals continue to collaborate with J.S. Held technical experts, our clients and Industry Reports readers will continue to benefit.” In 2018, a series of Industry Analyst Reports were launched to provide a comprehensive look at current industry trends and deal activity. Our reports currently examine the following industries: Autonomous, Battery, Blockchain & Cryptocurrency, Cannabis, Cybersecurity, IP Licensing Companies, and Semiconductors.

To learn more, download the Cannabis Industry Report or contact:

Cameron Pirochta | Cannabis Analyst | +1 312 377 8032 | cameron.piochta@jsheld.com

Paula Durham | Director, Corporate Finance | +1 602 279 7505 | pdurham@jsheld.com

Daniel Principe |Manager, Valuation & IP Strategy | +1 312 377 4426 | daniel.principe@jsheld.com

About Ocean Tomo, a part of J.S. Held

Established in 2003, Ocean Tomo provides Financial Expert, Management Consulting, and Advisory Services related to intellectual property (IP) and other intangible assets; corporate accounting investigations; regulatory and reporting obligations; solvency and restructuring; and contractual or competition disputes. Practice offerings address economic damage calculations and testimony; accounting investigations and financial forensics; technology and intangible asset valuation; strategy and risk management consulting; mergers and acquisitions; debt and equity private placement; and IP brokerage. Subsidiaries of Ocean Tomo include Ocean Tomo Investments Group, LLC, a registered broker-dealer.

As a part of J.S. Held, Ocean Tomo works alongside more than 1500 professionals globally and assists clients – corporations, insurers, law firms, governments, and institutional investors – on complex technical, scientific, and financial matters across all assets and value at risk.

J.S. Held is a global consulting firm providing technical, scientific, and financial expertise across all assets and value at risk. Our professionals serve as trusted advisors to organizations facing high-stakes events demanding urgent attention, staunch integrity, clear-cut analysis, and an understanding of both tangible and intangible assets. The firm provides a comprehensive suite of services, products, and data that enable clients to navigate complex, contentious, and often catastrophic situations.

Share article on social media or email:

PharmaPoint

Integration of this tool into our workflow increases the quality of care for our patients, all while lowering the cost of care. It’s a win/win scenario.

BIRMINGHAM, Ala. (PRWEB)
June 27, 2023

Next Level Medical is the newest partner to choose PharmaPoint’s XchangePoint platform to optimize medication treatment plans for patients under their care.

The partnership will target Next Level PRIME members plus their spouses and dependents that have been diagnosed with diabetes, hypertension or high cholesterol. XchangePoint’s MedTransition platform will proactively help identify patients that are nonadherent or have potential interactions with their drug treatment plan.

“XchangePoint is going to be the tool that allows us to prioritize our high-risk patients and monitor critical extended care touchpoints around medication adherence, potential drug interactions, duplicate therapies and drug/allergy interactions,” says Dr. Juliet Breeze, CEO of Next Level Medical, LLC. “Integration of this tool into our workflow increases the quality of care for our patients, all while lowering the cost of care. It’s a win/win scenario.”

Next Level PRIME members plus their spouses and dependents have unlimited access to Next Level locations seven days a week for primary, preventive, chronic and urgent care needs. Licensed Registered Nurses (RNs) are available by phone day and night to answer health questions and schedule appointments. PRIME members also have access to around the clock telemedical and virtual visits along with health and wellness coaching and behavioral health and emotional wellness counseling. Additionally, with PRIME, members have access to a full scope of high-quality care, including blood draws, lab testing, vaccines/immunizations and health screenings.

“I have always had an enormous amount of respect for Dr. Breeze,” says Mike Plaia, CEO of PharmaPoint. “She and her leadership team use a visionary care model to offer patients a seamless experience through the continuum of their healthcare journey. Partnering with an organization committed to providing excellent value-based care by removing any barriers that can occur between the provider and patient is the perfect collaborative effort for us. We are confident that our XchangePoint platform will further enable them to meet their goals.”

About PharmaPoint

PharmaPoint is an innovative, technology-enabled pharmacy management and software company. XchangePoint, our proprietary integrated workflow management system supporting medication management across care transitions, is designed for pharmacy and care team members to drive medication optimization for at-risk patients in the acute, post-acute and ambulatory care settings. Additionally, through the management of outpatient retail pharmacies for hospitals, health systems and physician groups, our commitment to completing the care continuum results in improved patient health and satisfaction, reduced healthcare costs, and provides clients with a source of ancillary income. Headquartered in Birmingham, Ala., PharmaPoint has been recognized as one of the most innovative, inspiring and fastest growing private companies for six consecutive years by Inc. Magazine. For more information about our company, please visit http://www.pharmapoint.com.

About Next Level Medical, LLC

Next Level Urgent Care was founded on the belief that it is possible to provide high-quality, cost-effective medical care for all who need immediate attention for non-life-threatening illnesses and injuries. As the first organization in Texas to achieve Urgent Care Center Accreditation through the American Academy of Urgent Care Medicine (AAUCM), a voluntary evaluation that measures the quality of services and performance against nationally recognized standards, Next Level Urgent Care clinics provide an excellent alternative for the treatment of sprains, strains, fractures, lacerations, allergies, rashes and congestion issues. Unlike retail walk-in clinics, all Next Level facilities have x-ray equipment on site and employ providers who are procedurally trained to handle acute urgent medical conditions that are not life-threatening. With convenient locations throughout the Houston, San Antonio, and Austin areas, clinics are open seven days a week until 9 p.m. For more information, please visit http://www.nextlevelurgentcare.com.

####

Share article on social media or email:

“With this training on the innovative ‘Trifecta Lift’, I aim to provide fellow medical professionals with the necessary tools and knowledge to elevate their skills and deliver superior results for their patients,” says Dr. Parsa.

BEVERLY HILLS, Calif. (PRWEB)
June 27, 2023

Core Aesthetics is proud to announce the launch of an innovative training course led by renowned expert Dr. Kami Parsa, designed to revolutionize the field of lower eyelid surgical rejuvenation. The course features training on a modern surgical eyelid rejuvenation procedure called “Trifecta Lift” and will take place on Saturday, October 21, 2023, from 8:00 am to 11:00 am via Zoom. This comprehensive educational program offers medical professionals a unique opportunity to master advanced techniques and gain invaluable insights into achieving exceptional outcomes in lower eyelid procedures.

Lower eyelid surgical rejuvenation is a specialized area of cosmetic surgery that demands precision, expertise, and an in-depth understanding of the latest advancements in the field. Dr. Kami Parsa has been practicing Oculoplastic Surgery for the past 20 years and has performed over 10,000 eyelid procedures. One of his signature surgical techniques for lower eyelid rejuvenation is his “Trifecta Lift” procedure, which involves lower eyelid blepharoplasty, micro fat transfer, canthal suspension and skin tightening. This course covers everything from patient evaluation and selection and step-by-step surgical technique involved.

The training course, facilitated online by Dr. Parsa, promises an immersive learning experience that encompasses theoretical knowledge, practical demonstrations, and priority invitation to observe Dr. Parsa in surgery at his Beverly Hills clinic. Participants will have the opportunity to engage directly with Dr. Parsa, who will share his wealth of experience and expertise gained through years of successful procedures and research. Participants will also receive a downloadable course booklet, certificate of participation, treatment consent forms, and pre- and post-op care instructions.

Key features of the training course include:

Comprehensive Curriculum: The course curriculum covers a wide range of topics, including patient selection, preoperative assessment, surgical techniques, complication management, and postoperative care. Participants will gain a comprehensive understanding of lower eyelid surgical rejuvenation, ensuring they are equipped with the necessary skills to excel in this field.

Q&A Sessions: Throughout the training course, participants will engage in interactive question-and-answer sessions with Dr. Parsa, enabling them to seek clarification, delve deeper into specific topics, and benefit from his extensive knowledge and experience.

“Lower eyelid surgical rejuvenation is an intricate procedure that requires a delicate balance of artistry and technical expertise,” said Dr. Parsa. “With this training on the innovative ‘Trifecta Lift’, I aim to provide fellow medical professionals with the necessary tools and knowledge to elevate their skills and deliver superior results for their patients.”

The training course is open to ophthalmologists, plastic surgeons, dermatologists, and other medical professionals with a keen interest in lower eyelid surgical rejuvenation. Participants will receive a certificate of completion, validating their participation and highlighting their dedication to professional growth and excellence in patient care.

For more information about the training course and registration details, please visit https://www.coreaesthetics.com/modern-day-approach-to-lower-eyelid-surgical-rejuvenation/. Early Registration ends August 28th.

About Dr. Kami Parsa and Core Aesthetics:

Kami Parsa M.D. is a native of California. He attended UCLA and graduated with honors from the University of Southern California School of Medicine. Dr. Parsa completed a residency in ophthalmology at USC’s prestigious Doheny Eye Institute. He then completed a two-year sub-specialty fellowship in Oculoplastic & Reconstructive Surgery at the University of Miami’s Bascom Palmer Eye Institute, ranked by U.S. News and World Report as the number one program in the country. His current projects and research are focused on the use of minimally invasive modalities for periocular rejuvenation. To this end, Parsa is committed to advancing the field of oculoplastic surgery and regularly shares his knowledge through educational initiatives and training programs.

Core Aesthetics Academy was established to meet the demands of the rapid influx of diverse providers in the aesthetic market that need provider training and education to ensure quality and safety standards are maintained. The purpose of Core Aesthetic Academy is to provide the practitioner with a clear and systematic approach to the aesthetic patient at all levels of expertise – from novice to advanced practitioners. For additional information, please visit http://www.coreaesthetics.com.

Share article on social media or email:

Using the Chakra System as a Modern Diagnostic Tool

“The Chakra system as a diagnostic tool offers physicians increased clarity about their patients, and the benefit of personally experiencing less burnout, better health, and a kinder work/home balance.” –Leonard Perlmutter

AVERILL PARK, N.Y. (PRWEB)
June 27, 2023

Curriculum developer and faculty director Leonard Perlmutter (Ram Lev), and Jenness Cortez Perlmutter will present an important lecture on “The Ancient Chakra System as a Diagnostic Tool” at the American Meditation Institute’s 12th annual Heart and Science of Yoga CME Conference 17-21, 2023 at the Equinox Resort and Spa in Manchester, Vermont. The presentation is a component of AMI’s proprietary, comprehensive training in Yoga Science as Holistic Mind/Body Medicine, which was recently found in a peer-reviewed clinical study to reduce Burnout and Stress, is accredited by the American Medical Association for 34 CME credit hours, and will be offered simultaneously in-person and virtually on Zoom.

Since 1996, Leonard and Jenness Perlmutter have taught courses on the Chakra system as holistic mind/body medicine. Their mission for the past 27 years has been to unite Eastern philosophy with Western medical science. The Perlmutters are direct disciples of Swami Rama of the Himalayas––the medical pioneer who, in 1970, under laboratory conditions at the Menninger Institute in Topeka, Kansas, demonstrated that blood pressure, heart rate and the autonomic nervous system can be voluntarily controlled. These research demonstrations have been one of the major cornerstones of the modern mind/body medicine movement.

Commenting on the effectiveness of the Chakra system, Leonard Perlmutter states that, “by employing the ancient Chakra system as a diagnostic tool in their own lives, physicians and other medical providers can experience less burnout, better health, more creativity and kinder work/home balance. By learning to employ their knowledge of Chakra psychology (subtle emotional/mental causes of stress), physicians will be able to diagnose and treat dis-ease with greater clarity and intuitive understanding.”

This “Heart and Science of Yoga” CME conference is dedicated to providing quality, comprehensive and evidence-based education. By design, it offers a broad curriculum of Yoga Science as mind/body medicine to relieve and prevent physician burnout. In addition to the lecture on the “Chakra System as a Diagnostic Tool,” topics at this year’s conference will include instruction on AMI Meditation, Epigenetics, mantra science, yoga psychology, resiliency, mind function optimization, food as medicine, Ayurveda, easy-gentle yoga, lymph system detoxification, and a physician panel discussion which will share how other healthcare providers have successfully incorporated Yoga Science tools into their own medical practice and home life.

The dedication, enthusiasm, and teaching methodology of the entire AMI faculty create a dynamic and interactive course for their students. Each faculty member is committed to the advancement and training of Yoga Science as holistic mind/body medicine. In addition to Leonard Perlmutter and Jenness Cortez Perlmutter, other presenters include: Mark Pettus MD, board certified internist and nephrologist and Director of Medical Education and Population Health of Berkshire Health Systems; Kristin Kaelber MD, PhD, board certified in Internal Medicine and Pediatrics; Renee Rodriguez-Goodemote, MD, Medical Director of the Saratoga Hospital Community Health Center; Anthony Santilli MD, board certified in Pulmonary and Critical Care Medicine; Jesse Ritvo MD, Assistant Medical Director, Inpatient Psychiatry, University of Vermont Health Center; Joshua Zamer, MD, Medical Director for Addiction Medicine at Saratoga Hospital Community Health Center and Chairman of the Department of Family Practice; Jenness Cortez Perlmutter, co-founder and faculty member of The American Meditation Institute; Anita Burock-Stotts, MD, board certified in Internal Medicine; Janine Pardo MD, board certified in Internal Medicine, and Gustavo Grodnitzky PhD, Chair of the AMI Psychological Education Committee.

Since 2009, this conference core curriculum has been endorsed by medical pioneers Dean Ornish MD, Larry Dossey MD, and Bernie Siegel MD. According to previous attendee Kristin Kaelber, MD, a board certified internist in Cleveland, Ohio, “the material presented in AMI’s CME conference represents the future of medical education. It has provided me the practical tools to be a better physician, wife, mother and friend. Anyone burdened by the stress and burnout of practicing medicine today definitely needs this wisdom.”

-30-

About the American Meditation Institute

The American Meditation Institute is a 501(c)3 non-profit educational organization devoted to the teaching and practice of Yoga Science, AMI Meditation® and its allied disciplines as Mind/Body Medicine. In its holistic approach to wellness, AMI combines the healing arts, philosophy and spirituality of the East with the practicality of modern Western medical science. The American Meditation Institute offers a wide variety of courses, conferences and webinars. AMI also publishes “Transformation” a bi-monthly Journal of Yoga Science as Holistic Mind/Body Medicine.

Call 518.674.8714 for interviews and a snail mail or email subscription.

Media Contact:

Robert Washington

PO Box 430

Averill Park, NY 12018

Tel: 518-674-8714

Fax: 518-674-8714

Share article on social media or email:

Rare Cannabinoid Company’s new, improved extra strength THCV Gummies bottles now contain 30 gummies instead of 15 and have added CBD, but cost less than before.

The addition of CBD to our high potency THCV gummies will enhance customers’ experience with this energizing, appetite suppressing cannabinoid.

HONOLULU (PRWEB)
June 27, 2023

Pioneering hemp brand, Rare Cannabinoid Company has launched new, improved extra strength THCV gummies. THCV is a rare cannabinoid found in hemp and cannabis that acts like a stimulant, increasing focus and energy, while decreasing appetite, which may aid concentration, exercise, and weight loss.

Rare Cannabinoid Company’s THCV gummies bottles now contain 30 gummies and are sold for $99. Each gummy contains 12.5mg THCV and 10mg CBD per gummy.

Bottles used to contain 15 THCV gummies and were sold for $109. Each gummy contained 25mg THCV per gummy and zero CBD.

The brand’s gummies with THCV still contain more THCV than any others on the market, but the new formula allows people to control their dosing more precisely.

“Our gummies were so strong that we advised people to take just half to one gummy at a time and some customers told us they were only taking a quarter or one-third of a gummy, which was messy and difficult for them. Our gummies’ new strength makes it much easier for people dose them easily and correctly,” said a company spokesperson.

The addition of CBD oil was also important to the Hawaiian brand as they believe that cannabinoids work best when taken together to enhance effects.

“We strongly believe in the entourage effect and advise people to use specific rare cannabinoids to enhance their full or broad spectrum CBD base oil. However, we realized that some people prefer to have one product that does it all. By adding CBD oil to our THCV gummies, our customers can really feel the heightened effects even if they don’t consume other hemp products,” the spokesperson said.

“The addition of CBD to our high potency THCV gummies will enhance customers’ experience with this energizing, appetite suppressing cannabinoid.”

Rare Cannabinoid Company’s THCV gummies are still vegan, low in sugar, and are naturally lemon flavored.

Rare Cannabinoid Company was also the first to create a pure THCV oil tincture and one-to-one blend of THCV CBD oil with full spectrum Hawaiian CBD.

The brand offers a wide selection of CBD, THC, rare cannabinoid, and terpene oils and gummies.

“Many customers like to combine our THCV gummies with our THC Mood Gummies,” said the spokesperson.

Mood Gummies contain hemp-derived Delta-9-THC as well as CBC (cannabichromene) for mood improvement and CBD oil.

“People like how the THCV curbs the THC munchies and by combining the two, they also enjoy an energetic sativa feel akin to strains like Durban Poison and Doug’s Varin,” they said.

Those interested in trying the THC Mood Gummies can receive a coupon code for a free packet of 10 gummies ($25 value) by signing up to receive the company’s newsletter.

Rare Cannabinoid Company prides itself on offering a full apothecary of cannabinoids, including CBN products for sleep, CBG gummies and oils for discomfort, and CBDV oil for sociability. They also have premium full and broad spectrum Hawaiian CBD base oils, gummies, Pet CBD, topicals and more.

Products can be found in more than 400 stores across the United States, Asia, and South America. They can also be purchased online and shipped worldwide (apart from locations where CBD is not allowed.)

Brick-and-mortar stores interested in stocking Rare Cannabinoid Company and Hawaiian Choice products can fill out a wholesale application or get in touch at wellnessorders.com.

Share article on social media or email:

Saner and Nijveldt will explore processes to compose drug labels, including the utilization of the structured product labeling XML format, offering an alternative process that is more accurate and faster than traditional processing methods.

TORONTO (PRWEB)
June 27, 2023

Gary Saner, Sr. Manager of Information Solutions Life Sciences at Reed Tech, and Gerrit-Jan Nijveldt, Global Labeling Consultant at Opus Regulatory, will be presenting a free webinar focused on enhancing the process of preparing patient and public-facing US drug product information, titled “Structured Product Labeling XML Composition: Enhancing the US Drug Label Management Process.” The webinar will take place on Thursday, July 13, 2023, at 10am EDT.

The webinar will address the multiple challenges faced in preparing accurate and regulated drug product information. Saner and Nijveldt will explore processes to compose drug labels, including the utilization of the structured product labeling XML format, offering an alternative process that is more accurate and faster than traditional processing methods.

“Effectively communicating drug-related information is crucial not only for the FDA but also for the drug product presence in the marketplace. This webinar aims to equip professionals with the knowledge to transform the process and ensure that the information delivered is both accurate and effective,” said Nijveldt.

The webinar is designed for a range of professionals, including drug information composition and publishing staff, drug labeling team members, regulatory affairs/operation leaders, product managers and marketing leaders, global strategy business managers, quality leaders and those involved with regulatory ad promotions.

Participants will learn about the US Food and Drug Administration (FDA) drug information regulations, an enhanced drug information processing method and time and cost savings in revamping the composition approach.

“With the fast-paced nature of the life sciences industry, it’s essential that professionals stay updated with the latest regulations and authoring and submission methods. This webinar is a step towards that goal, providing participants with the knowledge to make informed decisions and work more efficiently,” added Saner.

For more information, or to register for this event, visit Structured Product Labeling XML Composition: Enhancing the US Drug Label Management Process.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: